Strand Therapeutics develops new class of mRNA molecules for cancer The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases
Poolbeg’s cytokine release syndrome drug shows potential Data supports Poolbeg’s strategic expansion of POLB 001